Related Experiment Video
Updated: Apr 23, 2026
07:07
A Melanoma Patient-Derived Xenograft Model
Published on: May 20, 2019
12.3K
Vulvar melanoma: a 33 years single Italian center experience
C Catalano1, A De Magnis, T Kanninen
1Department of Biomedical, Clinical and Experimental Sciences, University of Florence, Florence, Italy - asisti6@gmail.com.
Summary
Vulvar melanoma, a rare cancer, has a poor prognosis. This study highlights the challenges in diagnosis and treatment, confirming the need for further research into effective therapeutic strategies for this aggressive disease.
Area of Science:
- Gynecologic Oncology
- Dermatology
- Oncology
Background:
- Vulvar melanoma is an exceptionally rare malignancy.
- It is associated with a significantly poor patient prognosis.
Purpose of the Study:
- To present a clinical experience with primary vulvar melanoma.
- To analyze patient characteristics, treatment modalities, and outcomes.
Main Methods:
- Retrospective analysis of patients with primary vulvar melanoma over 33 years.
- Data collection included clinical presentation, surgical interventions, and follow-up.
- Patient classification used the 2009 melanoma staging system.
Main Results:
- Pain was the most frequent presenting symptom, followed by ulceration and bleeding.
- The average age at diagnosis was 61.4 years.
- Regional recurrence was observed in 44.4% of cases, with a high mortality rate.
Conclusions:
- Vulvar melanoma demonstrates a consistently poor prognosis.
- Current treatment trends lean towards less aggressive approaches, though evidence is limited.
- The roles of sentinel lymph node biopsy and adjuvant therapies remain subjects of ongoing debate.
Related Concept Videos
01:30Skin Cancer
5.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.2K
02:56Treatment Resistant Cancers
2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
02:21Cancers Originate from Somatic Mutations in a Single Cell
12.2K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.2K
02:07Tumor Progression
6.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.1K
01:21Cancer Survival Analysis
857
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
857
01:27Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K